CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rapid growth in the geriatric population
4.1.2. Increasing awareness and adoption of preventive healthcare
4.1.3. Growing incidence of renal disorders
4.1.4. Favourable government initiatives to promote renal health
4.2. Market Restraints & Challenges
4.2.1. Identification of novel renal dysfunction biomarkers
4.2.2. Limited usage of creatinine assay kits in IVD
4.3. Market Opportunities
4.3.1. High growth potential in emerging economies
4.3.2. Emerging markets offer significant growth opportunities
CHAPTER 5. GLOBAL CREATININE ASSAY KITS MARKET – BY TYPE
5.1. Introduction
5.2. Creatinine-Pap Test Kits
5.3. Jaffe’s Kinetic Test Kits
5.4. Elisa Test Kits
CHAPTER 6. GLOBAL CREATININE ASSAY KITS MARKET – BY TESTS
PERFORMED
6.1 Introduction
6.2. Number of creatinine tests performed, by region
6.3. Number of creatinine tests performed, by type
CHAPTER 7. CREATININE ASSAY KITS MARKET - BY SAMPLE TYPE
7.1. Introduction
7.2. Blood/Serum
7.3. Urine
7.4. Other Samples
CHAPTER 8. GLOBAL CREATININE ASSAY KITS MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL CREATININE ASSAY KITS MARKET - COMPANY
PROFILES
9.1. Arbor Assays LLC.
9.2. Biovision Inc.
9.3. Tulip Diagnostics Private Limited.
9.4. Cell Biolabs Inc.
9.5. Bioassay Systems LLC.
9.6. Genway Biotech.
9.8. Wako Pure Chemical Industries, Ltd.
9.8. Crystal Chem Inc.
9.8. Cayman Chemical.
9.8. Enzo Life Sciences, Inc.
9.8. Quidel Corporation.
9.12. Abbott Laboratories.
9.13. Abcam PLC.
9.14. The Merck Group.
9.15. Thermo Fisher Scientific Inc.
CHAPTER 10. GLOBAL CREATININE ASSAY KITS MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures